Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023.
September 24, 2023
Share
Certain A-Shares of Sirio Pharma Company Limited are subject to a Lock-Up Agreement Ending on 25-SEP-2023. These A-Shares will be under lockup for 1462 days starting from 24-SEP-2019 to 25-SEP-2023.
Details:
The Company's holding shareholder Guangdong Guanghui Investment Co., Ltd., actual controllers Lin Peiqing and Chen Qiong, and shareholders Gao Feng, Lin Peichun, Lin Qixiong, and Lin Peina have agreed not to dispose of their interest for a period of 36 months from the date of listing.
The Company's shareholders Shantou Zhengnuo Investment Management Partnership Enterprise (Limited Partnership), Yao Zhuangmin, and Yang Rui have agreed not to dispose of their interest for a period of 12 months from the date of listing.
After the expiry of the lock-up period, the parties promise that yearly transfer of shares made by them will not exceed 25% of the holding, both direct and indirect, held by the present parties.
Sirio Pharma Co., Ltd. is a China-based company principally engaged in the research and development, production and sales of nutritional health food. The Company's main products include soft capsules, tablets, powders, soft candy, hard capsules and oral liquids. The Company's own brand is WEWOW nutritional health food. The Company distributes its products both in the domestic market and to overseas markets.